In this Law360 article, Steven Tenn considers how the FTC undertook its recent remedy study, and compares it to an alternative approach that is widely employed in the economics literature. The article concludes that the two approaches are complementary, with both expanding our understanding of the real-world performance of merger remedies. To read the article, click the link below.
A tale of two stakeholder groups in regulating healthcare AI
Despite significant spending on healthcare in the US, the industry is slow to adopt AI technology that can cut costs and improve efficiency. In this CPI...